CIS Pharma is an innovator in the biotech industry. Our motivation is to improve patient care in oncology and eye care. In our laboratories, we synthesize novel molecules and develop new biomaterials to increase precision, efficacy and safety of therapies.
Products, services, technology
Radiopharmaceuticls: Radioligands to target L1CAM and B7H3, proprietary payload technology to improve conjugation process
Ophthalmology – intracameral antibiotics, contact lens care products, contact lens coating technology and connected eye-drop dispenser.
We collaborate with financial partners, clinicians and scientists in industry and academia to commercialize our technology platforms.